Astrana Health (NASDAQ:ASTH – Free Report) had its price target boosted by Robert W. Baird from $54.00 to $67.00 in a research report report published on Thursday, Benzinga reports. They currently have an outperform rating on the stock.
Other research analysts also recently issued reports about the stock. Truist Financial increased their target price on shares of Astrana Health from $50.00 to $59.00 and gave the company a buy rating in a research report on Friday, August 9th. Stifel Nicolaus lifted their target price on shares of Astrana Health from $48.00 to $60.00 and gave the stock a buy rating in a research note on Thursday, August 1st. Finally, Baird R W upgraded Astrana Health to a strong-buy rating in a research note on Thursday, May 30th. Four investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of Buy and a consensus target price of $59.00.
Check Out Our Latest Research Report on ASTH
Astrana Health Stock Performance
Astrana Health (NASDAQ:ASTH – Get Free Report) last released its quarterly earnings results on Wednesday, August 7th. The company reported $0.40 EPS for the quarter, beating analysts’ consensus estimates of $0.39 by $0.01. The business had revenue of $486.30 million during the quarter, compared to analyst estimates of $440.68 million. Astrana Health had a return on equity of 10.22% and a net margin of 4.29%. Astrana Health’s quarterly revenue was up 39.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.28 EPS. On average, equities analysts forecast that Astrana Health will post 1.42 earnings per share for the current year.
About Astrana Health
Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.
Featured Stories
- Five stocks we like better than Astrana Health
- Dividend Payout Ratio Calculator
- This Small Cap Wealth Management Stock Could Provide Big Returns
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Bumble’s Valuation Hits an All-Time Low, Can Its Fortunes Change?
- What Does Downgrade Mean in Investing?
- MarketBeat Week in Review – 8/12 – 8/16
Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.